By Tony Simone, Special to The Conway Daily Sun ...

With nearly half of all pregnancies worldwide being unintended, the need for effective, reversible male contraceptives ...

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive ...

Detailed price information for Amylyx Pharmaceuticals Inc (AMLX-Q) from The Globe and Mail including charting and trades.

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, non-invasive tracking and optimized treatment for diabetic patients.

Hesperos creates first organ-on-a-chip digital twin to predict drug responses, setting a new benchmark for New Approach ...

Part three of the trial will involve patients at higher risk of cardiovascular disease due to obesity and elevated CRP levels.

The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a ...